David Reddy
David Reddy is the director general of the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA), where he plays a critical role in shaping policies related to the pharmaceutical industry and public health. He has been an advocate for collaboration between governments and the pharmaceutical sector to enhance global health preparedness and response, particularly in the face of pandemics. Reddy's insights are influential in discussions about vaccine equity and the distribution of medical technologies, especially for developing countries.
Not in the pool (under ¢1).
Recent news mentions
David Reddy emphasizes the critical role of the pharmaceutical industry in pandemic preparedness.
WHO-Mitgliedstaaten verabschieden Pandemievertrag – Details im Überblick
Switzerland· 2025-05-20
David Reddy emphasized the importance of intellectual property and legal security for ensuring investments in the pharmaceutical sector.
Países chegam a acordo histórico na OMS para prevenir e combater futuras pandemias
Brazil· 2025-04-16
David Reddy, director-general of the International Federation of Pharmaceutical Manufacturers and Associations, said the pandemic agreement is a starting point.
WHO countries strike landmark agreement on tackling future pandemics
New Zealand· 2025-04-16
David Reddy is the Director General of the International Federation of Pharmaceutical Manufacturers and Associations.
A l’OMS, les Etats avancent vers un compromis sur le texte de l’accord sur les pandémies
France· 2025-04-12
